Body & Mind Inc. · CSE:BAMM
Body & Mind — Investor Presentation (June 2025)
11 slides from Body & Mind's investor presentation, June 2025
Slide 1: Corporate Presentation
2025 BAMM CSE BMMJ OTC BODYandMIND.COM CORPORATE PRESENTATION
Slide 2: Disclaimer
DISCLAIMER Legal Disclaimers & Cautionary Statement Regarding Forward Looking Statements This presentation (“Presentation”) relates to an entity that is directly and through its subsidiaries involved in the United States cannabis industry insofar as its business activities include the production, ma
Slide 3: Company Overview
Company OVERVIEW MULTI-STATE OPERATOR WITH OPERATIONS FOCUSED STRATEGY RETAIL Dispensary operations in California CA and Illinois IL. Dispensary under development in New Jersey NJ PLATFORM APPROACH Expansion focuses on limited license states and jurisdictions, entering new markets through NJ lower c
Slide 4: Vision + Strategy
Vision + STRATEGY THE FOUNDATION OF OUR BUSINESS IS DRIVEN BY 4 KEY DIRECTIVES IDENTIFY OPTIMIZE ASSESS EXECUTE Low-cost method to Upgrade, and then integrate new Acquisition opportunities using Acquisitions using creative, enter a new market through assets into the BaM family using “feet on the gro
Slide 5: California: San Diego + Long Beach + Seaside
CALIFORNIA San Diego + Long Beach + Seaside • Long Beach dispensary awarded best dispensary in Long Beach 2018 and 2019. Rebranded to a BODYandMIND Dispensary in 2022. Long Beach Dispensary currently under agreement for sale. LONG BEACH + SAN DIEGO • San Diego dispensary (60% ownership) opened April
Slide 6: New Jersey
NEW JERSEY Market BaM OPPORTUNITY OVERVIEW • BODYandMIND branded adult-use Population of approximately dispensary in development 9.26 million* • State annual license approved in addition to Only 29% of NJ municipalities local pre-approval for adult-use cannabis allow some form of adult–use dispensar
Slide 7: Balance Sheet + Financials
TM Balance Sheet + FINANCIALS FINANCIAL Please refer to Body and Mind 10-K and Trading METRICS 10-Q financial statements posted on Edgar. OVERVIEW *Adjusted EBITDA is a Non-GAAP metric Reported FY2021 Revenue used by management that does not have any STOCK PRICE: BAMM CSE US$ 26.90 million standardi
Slide 8: Leadership
LEADERSHIP LEADERSHIP MICHAEL MILLS TRIP HOFFMAN DONG H. SHIM President, CEO and Director COO and Director CFO • Over 25 years in senior • Past CEO of a Colorado licensed • Chartered professional Accountant in management positions in industries cultivation and dispensary company. Canada and a Regist
Slide 9: Leadership
LEADERSHIP LEADERSHIP ALEXIS PODESTA BRENT REUTER Director Director • Past Secretary of California Business, • Mr. Reuter is CEO of Aryza Canada, a Consumer Services and Housing Agency and financial technology company focused on directed a $4.75 billion budget and nearly automation of debt and credi
Slide 10: Execution
Execution Track record of license success, value acquisitions and development LICENSES: Lowest cost method to enter a new market. License wins as Nevada, Ohio, Arkansas and Illinois. Ongoing license applications for limited license opportunities. ACQUISITIONS: Value acquisitions completed to enter n
Slide 11: Investor Relations
BAMM CSE - BMMJ OTC BODYandMIND.com Investor Relations 1-800-361-6312 ir@bodyandmind.com